Research programme: leucine/nicotinic acid - NuSirt Biopharma

Drug Profile

Research programme: leucine/nicotinic acid - NuSirt Biopharma

Alternative Names: Leucine/niacin; Niacin/leucine; Nicotinic acid/leucine

Latest Information Update: 09 Jul 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator NuSirt Biopharma
  • Class Branched-chain amino acids; Essential amino acids; Nicotinic-acids; Small molecules; Vitamins
  • Mechanism of Action GPR109A receptor agonists; GPR109B receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Atherosclerosis; Hyperlipidaemia

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top